Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
phenotype | 0.300 | None | 1.000 | 4 | 0 | 2011 | 2014 | ||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
interleukin 1 beta | 0.276 | 0.962 | 0.13 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
transforming growth factor beta 1 | 0.287 | 0.962 | 3.7E-02 |
|
phenotype | 0.300 | None | 1.000 | 5 | 0 | 2013 | 2016 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
phenotype | 0.300 | None | 1.000 | 2 | 0 | 2009 | 2013 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
catenin beta 1 | 0.303 | 0.885 | 1.00 |
|
phenotype | 0.300 | None | 1.000 | 2 | 0 | 2013 | 2017 | ||||||||
|
matrix metallopeptidase 9 | 0.305 | 0.923 | 1.9E-17 |
|
phenotype | 0.310 | None | 1.000 | 7 | 0 | 2003 | 2014 | ||||||||
|
phosphatase and tensin homolog | 0.305 | 0.923 | 0.26 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
insulin like growth factor 1 | 0.318 | 0.885 | 0.27 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
C-C motif chemokine ligand 2 | 0.321 | 0.962 | 0.61 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
toll like receptor 4 | 0.321 | 0.962 | 4.6E-09 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
estrogen receptor 1 | 0.324 | 0.962 | 1.00 |
|
phenotype | 0.300 | None | 1.000 | 2 | 0 | 2016 | 2017 | ||||||||
|
actin beta | 0.325 | 0.923 | 0.99 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
hypoxia inducible factor 1 subunit alpha | 0.327 | 0.923 | 0.98 |
|
phenotype | 0.300 | None | 1.000 | 2 | 0 | 2003 | 2018 | ||||||||
|
mitogen-activated protein kinase 1 | 0.330 | 0.923 | 1.00 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
matrix metallopeptidase 2 | 0.333 | 0.923 | 0.84 |
|
phenotype | 0.300 | None | 1.000 | 4 | 0 | 2008 | 2013 | ||||||||
|
epidermal growth factor | 0.357 | 0.923 | 8.5E-17 |
|
phenotype | 0.300 | None | 1.000 | 5 | 0 | 2005 | 2016 | ||||||||
|
catalase | 0.359 | 0.962 | 1.6E-10 |
|
phenotype | 0.300 | None | 1.000 | 2 | 0 | 2011 | 2012 | ||||||||
|
C-X-C motif chemokine receptor 4 | 0.362 | 0.923 | 1.8E-02 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
microRNA 21 | 0.363 | 0.846 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||
|
fibronectin 1 | 0.365 | 0.962 | 1.4E-03 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
vimentin | 0.372 | 0.846 | 0.71 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
interleukin 1 receptor antagonist | 0.373 | 0.923 | 3.1E-02 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
hepatocyte growth factor | 0.374 | 0.885 | 1.00 |
|
phenotype | 0.300 | None | 1.000 | 2 | 0 | 1998 | 2005 |